We are aware some users might find it difficult to log into our site. We are working on this issue and hope to have it resolved shortly.
Journal scan

Lung cancer patients could be given choice over treatment


Having radiotherapy once a day for 6.5 weeks, or twice a day for 3 weeks – when combined with chemotherapy – is equally good at treating small cell lung cancer that has not spread, a study suggests.

Patients with small cell lung cancer may benefit from daily radiotherapy. Photo: Science Photo Library

International researchers studied about 550 patients from across the world in the CONVERT trial – the largest ever trial completed in this group of patients.

Participants were split into 2 groups: the first group received radiotherapy twice a day over 3 weeks, and the second received radiotherapy once a day at a higher dose over 6.5 weeks. All patients also had chemotherapy.


Survival in both groups was similar: 56% who had radiotherapy twice a day survived for 2 years, compared with 51% of patients given radiotherapy once a day.



Want to read more?

Unlock full access to RCNi Plus today

Save over 50% on your first three months:

  • Customisable clinical dashboard featuring 200+ topics
  • Unlimited online access to all 10 RCNi Journals including Nursing Standard
  • RCNi Learning featuring 180+ RCN accredited learning modules
  • NMC-compliant RCNi Portfolio to build evidence for revalidation
  • Personalised newsletters tailored to your interests

This article is not available as part of an institutional subscription. Why is this?